Viaud; Sophie Patent Filings

Patent	Date
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment Grant 11,344,586 - Zitvogel , et al. May 31, 2	2022-05-31
Car T Cell Methods And Constructs App 20220090132 - Jolly; Douglas J. ; et al.	2022-03-24
Chimeric Antigen Receptor Effector Cell Switches With Humanized Targeting Moieties And/or Optimized Chimeric Antigen Receptor Interacting Domains And Uses Thereof App 20220073597 - YOUNG; Travis S. ; et al.	2022-03-10
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof Grant 11,174,306 - Young , et al. November 16, 2	2021-11-16
Microbiota Composition, As A Marker Of Responsiveness To Chemotherapy, And Use Of Microbial Modulators (pre-, Pro- Or Synbiotics) For Improving The Efficacy Of A Cancer Treatment App 20200360449 - ZITVOGEL; Laurence ; et al.	2020-11-19
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment Grant 10,646,521 - Zitvogel , et al.	2020-05-12
Chimeric Antigen Receptor Effector Cell Switches With Humanized Targeting Moieties And/or Optimized Chimeric Antigen Receptor In App 20190359697 - YOUNG; Travis S. ; et al.	2019-11-28
Microbiota Composition, As A Marker Of Responsiveness To Chemotherapy, And Use Of Microbial Modulators (pre-, Pro- Or Synbiotics) For Improving The Efficacy Of A Cancer Treatment App 20160303172 - ZITVOGEL; Laurence ; et al.	2016-10-20

Patent

Date

Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
Grant 11,344,586 - Zitvogel , et al. May 31, 2

2022-05-31

Car T Cell Methods And Constructs
App 20220090132 - Jolly; Douglas J. ; et al.

2022-03-24

Chimeric Antigen Receptor Effector Cell Switches With Humanized Targeting Moieties And/or Optimized Chimeric Antigen Receptor Interacting Domains And Uses Thereof
App 20220073597 - YOUNG; Travis S. ; et al.

2022-03-10

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
Grant 11,174,306 - Young , et al. November 16, 2

2021-11-16

Microbiota Composition, As A Marker Of Responsiveness To Chemotherapy, And Use Of Microbial Modulators (pre-, Pro- Or Synbiotics) For Improving The Efficacy Of A Cancer Treatment
App 20200360449 - ZITVOGEL; Laurence ; et al.

2020-11-19

2020-05-12

Chimeric Antigen Receptor Effector Cell Switches With Humanized Targeting Moieties And/or Optimized Chimeric Antigen Receptor In
App 20190359697 - YOUNG; Travis S. ; et al.

2019-11-28

2016-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Viaud; Sophie

Patent Applications and Registrations